Aventis Pharma S.A. v. Hospira, Inc.
2:07-cv-08137
Overview
Parties
Defendant
Hospira, Inc. Operating Company
Represented By
5 Attorneys ListedRuss August and Kabat
Russ August and Kabat, 12424 Wilshire Boulevard 12th Floor
WINSTON & STRAWN LLP
35 W. Wacker Drive, Chicago, IL 60601-9703
Winston and Strawn
Winston and Strawn, 35 West Wacker Drive
Winston and Strawn LLP
333 South Grand Avenue 38th Floor, Los Angeles, CA 90071-1543
WINSTON & STRAWN LLP
1700 K. Street, N.W., Washington, DC 20006-3817
Plaintiff
Aventis Pharmaceuticals Inc. Operating Company
Represented By
5 Attorneys ListedFinnegan Henderson Farabow Garrett & Dunner LLP
3500 SunTrust Plaza, 303 Peachtree Street N E
Finnegan Henderson Farabow Garrett & Dunner
Finnegan Henderson Farabow Garrett & Dunner, Stanford Research Pk
Morris Polich and Purdy LLP
1055 West 7th Street Suite 2400, Los Angeles, CA 90017-2503
Finnegan Henderson Farabow Garrett & Dunner
Finnegan Henderson Farabow Garrett & Dunner, 901 New York Avenue NW
Finnegan Henderson Farabow Garrett and Dunner
Finnegan Henderson Farabow Garrett and Dunner, 901 New York Avenue NW
Aventis Pharma S.A. NPE (Individual / Inventor)
Represented By
5 Attorneys ListedFinnegan Henderson Farabow Garrett & Dunner LLP
3500 SunTrust Plaza, 303 Peachtree Street N E
Finnegan Henderson Farabow Garrett & Dunner
Finnegan Henderson Farabow Garrett & Dunner, Stanford Research Pk
Morris Polich and Purdy LLP
1055 West 7th Street Suite 2400, Los Angeles, CA 90017-2503
Finnegan Henderson Farabow Garrett & Dunner
Finnegan Henderson Farabow Garrett & Dunner, 901 New York Avenue NW
Finnegan Henderson Farabow Garrett and Dunner
Finnegan Henderson Farabow Garrett and Dunner, 901 New York Avenue NW
Court & Judges
Court
District Court, C.D. California (cacd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,389,618 A Asserted | US Continuation / Sibling | View Official Patent → |
| 🇫🇷 France | FR 9008013 | France Counterpart | View Official Patent → |
| 🇫🇷 France | FR 2663639 B1 | France Counterpart | View Official Patent → |
| 🇺🇸 United States | US 72,131,591 A | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5389618
Mixtures of particular LMW heparinic polysaccharides for the prophylaxis/treatment of acute thrombotic events
|
Filed: 1993-07-16
Issued: 1995-02-14
|
Expired (Term Ended)
Expires: 2013-07-16
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).